Medline Inc. announces launch of secondary offering of Class A common stock
Medline Files Prospectus For Secondary Offering of 60M Shares On Behalf Of Selling Shareholders; To Repurchase $200M Of Stock From Selling Shareholders At Assumed Price Of $39.47/Share
Billionaire Hedge Fund Manager Calls Medline (MDLN) a Category Killer Despite a Frustrating Year
UBS Maintains Buy on Medline, Raises Price Target to $49
Citigroup Maintains Buy on Medline, Raises Price Target to $47
Leerink Partners Maintains Outperform on Medline, Raises Price Target to $46
Evercore ISI Group Maintains Outperform on Medline, Raises Price Target to $44
BTIG Reiterates Buy on Medline, Maintains $55 Price Target
Medline Inc (MDLN) Q3 2026 Earnings Call Highlights: Raised Guidance, Strong Cash Flow, and a ...
Medline (MDLN), What Is Behind The Fresh Attention?
Medical supply giant Medline laying off 304 workers
Medline Inc. (MDLN) Q3 2026 Earnings Call Transcript
Medline (MDLN) Reports Q3 Earnings: What Key Metrics Have to Say
Medline: Q3 Earnings Snapshot
Medline Reports Third Quarter and Nine Months 2026 Results
Medline Q3 2026 Earnings Call Transcript
Medline Inc. 2026 Q3 - Results - Earnings Call Presentation
Medline Announces $1B Buyback Plan
Medline Q3 Adj. EPS $0.44 Beats $0.35 Estimate, Sales $7.856B Beat $7.723B Estimate
Medline announces participation in the 2026 Jefferies Global Healthcare Conference
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.